Elliott B. Grossbard
- Immunology top 5%
- Genetics top 2%
- Hematology top 2%
- Rheumatology top 2%
- Radiology, Nuclear Medicine and Imaging top 5%
- Co-authors
- Michael E. WeinblattArthur KavanaughMark C. GenoveseDaniel B. MagilavyDonald G. PayanEsteban S. MasudaMuhammad BaluomEli O. Meltzer
- Topics
- Mast cells and histamine (10 papers)Monoclonal and Polyclonal Antibodies Research (9 papers)Chronic Myeloid Leukemia Treatments (6 papers)
- Cited by
- GeneticsHematologyImmunology
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Elliott B. Grossbard
31 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 101
- Immunology 823
- Genetics 522
- Hematology 493
- Rheumatology 465
- Radiology, Nuclear Medicine and Imaging 374
Countries citing papers authored by Elliott B. Grossbard
This map shows the geographic impact of Elliott B. Grossbard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elliott B. Grossbard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elliott B. Grossbard more than expected).
Fields of papers citing papers by Elliott B. Grossbard
This network shows the impact of papers produced by Elliott B. Grossbard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elliott B. Grossbard. The network helps show where Elliott B. Grossbard may publish in the future.
Co-authorship network of co-authors of Elliott B. Grossbard
This figure shows the co-authorship network connecting the top 25 collaborators of Elliott B. Grossbard. A scholar is included among the top collaborators of Elliott B. Grossbard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elliott B. Grossbard. Elliott B. Grossbard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 15 | |
| 2 | 33 | |
| 3 | Longer-term safety of fostamatinib (R788) in patients with rheumatoid arthritis. Analysis of clinical trial data from up to 2 years of exposure | 7 |
| 4 | 19 | |
| 5 | 299 | |
| 6 | 167 | |
| 7 | 56 | |
| 8 | 23 | |
| 9 | 267 | |
| 10 | 137 | |
| 11 | 35 | |
| 12 | 116 | |
| 13 | 13 | |
| 14 | 74 | |
| 15 | 23 | |
| 16 | 58 | |
| 17 | 45 | |
| 18 | 37 | |
| 19 | 148 | |
| 20 | 18 |
About Elliott B. Grossbard
Elliott B. Grossbard is a scholar working on Hematology, Internal Medicine and Immunology, having authored 32 papers that have together received 2.1k indexed citations. Recurring topics across this work include Mast cells and histamine (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Chronic Myeloid Leukemia Treatments (6 papers). The work is most often cited by research in Genetics (522 citations), Hematology (493 citations) and Immunology (823 citations). Elliott B. Grossbard has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Michael E. Weinblatt, Arthur Kavanaugh, Mark C. Genovese, Daniel B. Magilavy, Donald G. Payan, Esteban S. Masuda, Muhammad Baluom, Eli O. Meltzer, Robert Berkowitz and Polly Pine. Their work appears in journals such as New England Journal of Medicine, Blood and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.